Autopsy report · NCT00054704

Riluzole to Treat Depression in Bipolar Disorder

“Placebo was better than active drug.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 11 years 10 months before it stopped.
• 19 participants enrolled.
• Results were posted on the registry 1 year 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Institute of Mental Health (NIMH)

Sponsor type

US National Institutes of Health

Conditions

Bipolar Disorder

Interventions

Riluzole; Placebo

Participants

19

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.